- Presentations
- 2
- Markets
- 1
Sunlenca is a brand of Lenacapavir marketed by Gilead Sciences, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Lenacapavir
- Brand owner
- Gilead Sciences
- Registered in
- United States
- Strengths and forms
- kit, 300 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Sunlenca kit | Gilead Sciences | US FDA | Available on request |
| Sunlenca 300 mg tabletOral | Gilead Sciences | US FDA | Available on request |
Equivalent brands
Other brands of Lenacapavir.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Sunlenca
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.